These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15660198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Products of advanced glycation in patients with type 2 diabetes and vascular disease.
    Turk Z, Sesto M, Skodlar J, Ferencak G, Pokupec R, Turk N, Stavljenić-Rukavina A.
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):552-9. PubMed ID: 14503994
    [Abstract] [Full Text] [Related]

  • 3. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljenić-Rukavina A.
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
    Newkirk MM, LePage K, Niwa T, Rubin L.
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
    Haslbeck KM, Schleicher ED, Friess U, Kirchner A, Neundörfer B, Heuss D.
    Acta Neuropathol; 2002 Jul; 104(1):45-52. PubMed ID: 12070663
    [Abstract] [Full Text] [Related]

  • 10. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
    Gupta A, Tripathi AK, Tripathi RL, Madhu SV, Banerjee BD.
    Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
    [Abstract] [Full Text] [Related]

  • 11. Nerve lipid abnormalities in human diabetic neuropathy: a correlative study.
    Brown MJ, Iwamori M, Kishimoto Y, Rapoport B, Moser HW, Asbury AK.
    Ann Neurol; 1979 Mar; 5(3):245-52. PubMed ID: 443757
    [Abstract] [Full Text] [Related]

  • 12. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy.
    Malik RA, Tesfaye S, Thompson SD, Veves A, Hunter A, Sharma AK, Ward JD, Boulton AJ.
    Microvasc Res; 1994 Sep; 48(2):236-45. PubMed ID: 7854207
    [Abstract] [Full Text] [Related]

  • 13. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
    Nybo M, Poulsen MK, Grauslund J, Henriksen JE, Rasmussen LM.
    Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
    [Abstract] [Full Text] [Related]

  • 14. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z, Prázný M, Skrha J.
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [Abstract] [Full Text] [Related]

  • 15. Direct immunofluorescence findings in peripheral nerve from patients with diabetic neuropathy.
    Graham AR, Johnson PC.
    Ann Neurol; 1985 May; 17(5):450-4. PubMed ID: 3890701
    [Abstract] [Full Text] [Related]

  • 16. Lipid peroxides in type 2 diabetic patients with neuropathy.
    Migdalis IN, Triantafilou P, Petridou E, Varvarigos N, Totolos V, Rigopoulos A.
    Res Commun Mol Pathol Pharmacol; 2005 May; 117-118():5-12. PubMed ID: 18426075
    [Abstract] [Full Text] [Related]

  • 17. Light and electron microscopic changes in sural nerves in Ethiopian diabetics.
    Tekle Haimanot R, Abdulkadir J, Doyle D.
    Ethiop Med J; 1989 Jan; 27(1):1-8. PubMed ID: 2920707
    [Abstract] [Full Text] [Related]

  • 18. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
    Haslbeck KM, Schleicher E, Bierhaus A, Nawroth P, Haslbeck M, Neundörfer B, Heuss D.
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):288-91. PubMed ID: 15926115
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC, Burlina S, Lapolla A.
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.